Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SMYD2 inhibitors(SET and MYND domain containing 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC29H38Cl2N4O4 |
InChIKeyWVRBXBROEPXZHF-SANMLTNESA-N |
CAS Registry1868232-32-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Discovery | US | - |